Eqis Capital Management, Inc. Exact Sciences Corp Transaction History

Eqis Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $41,358 - $54,220	-735 Reduced 14.94%	4,185 $289,000
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $8,740 - $11,206	-148 Reduced 2.92%	4,920 $363,000
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $20,705 - $31,098	314 Added 6.6%	5,068 $345,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $297,980 - $451,867	4,754 New	4,754 $446,000
Q4 2017 Jan 25, 2018	SELL	$46.49 - $60.51 $216,039 - $281,189	-4,647 Closed	0 $0
Q3 2017 Oct 03, 2017	BUY	$37.05 - $47.12 $172,171 - $218,966	4,647	4,647 $219,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.